medium chain acyl dehydrogenase
Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency
6
Molecular basis of medium chain acyl coenzyme A dehydrogenase deficiency An A to G transition at position 985 that causes a lysine 304 to glutamate substitution in the mature protein is the single prevalent mutation
5
Prolonged QTc Interval in Association With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
8
Medium-chain Acyl-CoA dehydrogenase deficiency presenting with neonatal pulmonary haemorrhage
6
Mitochondrial trifunctional protein deficiency Catalytic heterogeneity of the mutant enzyme in two patients
9
Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *
10
A novel mutation in medium chain acyl CoA dehydrogenase causes sudden neonatal death
8
Familial Reye-Like Syndrome: A Presentation of Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
6
Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada
10
Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis
13
Economics of tandem mass spectrometry screening of neonatal inherited disorders
7
PPARα protein expression was increased by four weeks of intermittent hypoxic training via AMPKα2-dependent manner in mouse skeletal muscle
11
Sudden Child Death and `Healthy' Affected Family Members With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
8
The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario
8
Spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening
9
Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives
10
Child Neurology: Medium-chain acyl-coenzyme A dehydrogenase deficiency
5
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening
7
In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes
8
The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle
16